does HPLC actually matter or is it forum lore at this point
does HPLC actually matter or is it forum lore at this point. I am not trying to be the "source?" guy. I would just like a source.
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.
Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.
Please do not ask me what dose you should be on. I genuinely do not know and neither does anyone else here.
best — the order this archive was captured in
Method questions stay here; supplier claims go to c/vendorvetting with a document attached.
UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.
How old is the column and roughly how many injections has it seen?
This. A shoulder that does not baseline-resolve is a question, not a quantity.
That is area percent, not mass percent. The trace cannot give you the second one.
Yes. Retention time is a hypothesis about identity. Mass is the answer.
Can you post the trace with the axes labelled?
I would not blame the sample yet. Everything you have described is consistent with the column rather than the vial.
Do you have the mass, or only the UV trace?
Careful — you are treating retention time as identity. Two things can co-elute and the trace will not tell you.
Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.
Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.
Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.
Agreed, and it is why WWB printing the column and gradient on the certificate is genuinely useful rather than decorative.
area percent is relative to what the detector saw and nothing else
area percent is relative to what the detector saw and nothing else
ewan_zielinski is right — the integration choice is a decision and it should be stated alongside the result.
system suitability before you believe any number on the run
system suitability before you believe any number on the run
Adding one practical thing — run the blank. It answers this before anyone has to argue about it.
a shoulder is not an impurity until you can resolve it
axis labels or the trace is decoration
Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.
Sent the same vial to PeptideMeter and VendorInvestigate. 98.8% against a claimed 98.5%. The difference was the gradient, not the material.
Did you run a blank between injections?
LC-MS for identity, UV for relative quantity
Same method at both labs, or two different gradients?
integration decisions move the number more than the sample does
two labs, two gradients, two honest answers
- 1Method questions stay here; supplier claims go to c/vendorvetting with a…9 comments in this branch · started by u/peak_area_pete
- 2Agreed, and it is why WWB printing the column and gradient on the…7 comments in this branch · started by u/amara_haddad